The Sherwin-Williams Company (SHW) Stock Forecast
Data as of Jul 31, 2026Basic Materials · Current price $340.75 (-1.21%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 12, 2026 | Joshua Spector | UBS | $415.00 | +21.8% |
| Oct 29, 2025 | Michael Sison | Wells Fargo | $410.00 | +20.3% |
| Apr 15, 2025 | John Roberts | Mizuho Securities | $395.00 | +15.9% |
| Mar 10, 2025 | Laurence Alexander | Jefferies | $380.00 | +11.5% |
| Jan 31, 2025 | Ghansham Panjabi | Robert W. Baird | $370.00 | +8.6% |
| Jan 14, 2025 | Arun Viswanathan | RBC Capital | $438.00 | +28.5% |
| Jan 7, 2025 | John Roberts | Mizuho Securities | $408.00 | +19.7% |
| Jan 2, 2025 | Laurence Alexander | Jefferies | $423.00 | +24.1% |
| Oct 24, 2024 | Arun Viswanathan | RBC Capital | $446.00 | +30.9% |
| Oct 23, 2024 | Ghansham Panjabi | Robert W. Baird | $360.00 | +5.7% |
| Oct 23, 2024 | Duffy Fischer | Goldman Sachs | $410.00 | +20.3% |
| Oct 23, 2024 | Greg Melich | Evercore ISI | $400.00 | +17.4% |
| Oct 23, 2024 | Michael Leithead | Barclays | $370.00 | +8.6% |
| Oct 21, 2024 | Laurence Alexander | Jefferies | $445.00 | +30.6% |
| Sep 3, 2024 | John McNulty | BMO Capital | $400.00 | +17.4% |
| Aug 26, 2024 | Laurence Alexander | Jefferies | $415.00 | +21.8% |
| Jul 30, 2024 | Aron Ceccarelli | Berenberg Bank | $312.00 | -8.4% |
| Jul 24, 2024 | David Begleiter | Deutsche Bank | $385.00 | +13.0% |
| Jul 24, 2024 | Ghansham Panjabi | Robert W. Baird | $325.00 | -4.6% |
| Jul 24, 2024 | Michael Leithead | Barclays | $355.00 | +4.2% |
Top Analysts Covering SHW
SHW vs Sector & Market
| Metric | SHW | Basic Materials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.25 | 2.36 | 2.42 |
| Analyst Count | 20 | 7 | 19 |
| Target Upside | +17.8% | +119.1% | +18.0% |
| P/E Ratio | 32.70 | -10.77 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $24.49B | $24.60B | $24.67B | 16 |
| 2027-03-31 | $5.67B | $5.79B | $5.86B | 5 |
| 2027-06-30 | $6.76B | $6.90B | $6.99B | 6 |
| 2027-09-30 | $6.85B | $6.99B | $7.08B | 9 |
| 2027-12-31 | $5.95B | $6.08B | $6.15B | 5 |
| 2028-03-31 | $6.02B | $6.15B | $6.23B | 4 |
| 2028-06-30 | $7.35B | $7.50B | $7.59B | 6 |
| 2028-09-30 | $7.46B | $7.62B | $7.71B | 9 |
| 2028-12-31 | $6.44B | $6.58B | $6.66B | 4 |
| 2029-12-31 | $27.65B | $28.19B | $28.66B | 12 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11.64 | $11.78 | $11.98 | 14 |
| 2027-03-31 | $2.29 | $2.35 | $2.39 | 5 |
| 2027-06-30 | $3.87 | $3.98 | $4.04 | 5 |
| 2027-09-30 | $4.13 | $4.24 | $4.31 | 5 |
| 2027-12-31 | $2.66 | $2.73 | $2.77 | 5 |
| 2028-03-31 | $2.42 | $2.49 | $2.53 | 7 |
| 2028-06-30 | $4.92 | $5.06 | $5.14 | 6 |
| 2028-09-30 | $5.48 | $5.63 | $5.72 | 6 |
| 2028-12-31 | $3.60 | $3.70 | $3.76 | 7 |
| 2029-12-31 | $15.79 | $16.19 | $16.54 | 2 |
Frequently Asked Questions
What is the analyst consensus for SHW?
The consensus among 20 analysts covering The Sherwin-Williams Company (SHW) is Buy with an average price target of $374.56.
What is the highest price target for SHW?
The highest price target for SHW is $446.00, set by Arun Viswanathan at RBC Capital on 2024-10-24.
What is the lowest price target for SHW?
The lowest price target for SHW is $275.00, set by Laurence Alexander at Jefferies on 2022-03-16.
How many analysts cover SHW?
20 analysts have issued ratings for The Sherwin-Williams Company in the past 12 months.
Is SHW a buy or sell right now?
Based on 20 analyst ratings, SHW has a consensus rating of Buy (2.25/5) with a +17.8% upside to the consensus target of $374.56.
What are the earnings estimates for SHW?
Analysts estimate SHW will report EPS of $11.78 for the period ending 2026-12-31, with revenue estimated at $24.60B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.